An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies.

Raffaele Palmirotta Barbara Leone Maria Laura De Marchis Giorgia Ludovici Annalisa Savonarola Patrizia Ferroni Tatjana Rundek Mario Roselli David Della-Morte Fiorella Guadagni

Blood Coagul Fibrinolysis

aDepartment of Advanced Biotechnologies and Bioimaging, Laboratory of Molecular Diagnostics bDepartment of Advanced Biotechnologies and Bioimaging, Laboratory of Thrombosis and Hemostasis, IRCCS San Raffaele Pisana, Rome, Italy cDepartment of Neurology, Miller School of Medicine, University of Miami, Miami, Florida, USA dMedical Oncology Unit, Tor Vergata Clinical Center, University of Rome eInterinstitutional Multidisciplinary BioBank (BioBIM), Department of Advanced Biotechnologies and Bioimaging, IRCCS San Raffaele Pisana, Rome, Italy.

Published: October 2013

Download full-text PDF	Source
http://dx.doi.org/10.1097/MBC.0b013e3283642d5b	DOI Listing

Publication Analysis

Top Keywords

identification double

double variant

variant methylenetetrahydrofolate

methylenetetrahydrofolate reductase

reductase gene

gene c677t

c677t a1298c

a1298c cis

cis configuration

configuration pharmacogenetic

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!